Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voclosporin Ophthalmic Solution in Dry Eye Syndrome
NCT04147650Phase 3Completed
- Sponsor
- Aurinia
- Start
- Oct 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Voclosporin ophthalmic solution in dry eye syndrome (DED), sponsored by Aurinia. Started Oct 2019; status: completed.
02
Drugs
Voclosporin ophthalmic solution
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT04147650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04147650.